comprehensive -WSS

comprehensive

author：comprehensive 2025-08-23 06:47:16 - browse：719

After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the definitive roster of leaders in health, medicine, and the life sciences whose work over the past year has advanced those fields.

There were, of course, many contenders to choose from. For this second annual list, we’ve selected just 46 — an homage to the number of chromosomes in human DNA. Many are well-known as changemakers; others are largely unheralded heroes. They are CEOs, philanthropists, government officials, and health advocates. All have compelling stories to tell.

Our editorial team painstakingly researched and identified hundreds of finalists. In winnowing down the list, judges placed special emphasis on people who have sought to help others and build community in these often-divisive times. One note: Our news coverage is independent of this list, and we remain committed to tough-minded reporting on the people and institutions shaping life sciences.

While I have your attention, I want to point you to some of our most talked-about exclusive stories in recent days: A new STAT investigation exposes how Medicare Advantage plans use algorithms to cut off care for seniors in need, and we took a closer look at how a Medicare Advantage business is strangling one of its first funders. We’re aggressively reporting on the consequences for biotech of the Silicon Valley Bank collapse.

And over the coming months, in our series “The Obesity Revolution,” we’ll explore a class of obesity drugs that is transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years.

For full access to our exclusive reporting, please consider purchasing a STAT+ subscription. Get 15% off an annual subscription by using promo code STAT15 when you check out.

As always, please reach out to me with feedback. I’m at [email protected].

Previous article： Medicare details structure of new drug price negotiation program
Next article： New research sheds light on how often breast cancer is overdiagnosed

knowledge

WSS

New research sheds light on how often breast cancer is overdiagnosed

The Bio Revolution is changing business and society

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Louisiana bill approved classifying abortion pills as controlled substances

Some medical students still think black patients feel less pain

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

hotspot

comprehensive

focus

Alkermes shareholders re

Lawsuit challenges CMS nursing home minimum staffing rule

Psychedelics group wrestles with new pharma identity

What we need to know about Arena Bioworks

Trump demands the U.S. pay no more for drugs than other countries … again

Pharma’s losing bet in New Jersey

23andMe had bad news about my health. I wish a person had delivered it

General Catalyst, Summa Health deal will turn on physician buy

As demand for Covid shots wanes, Moderna seeks its next success

Some medical students still think black patients feel less pain

Wikipedia

Why we need mandatory labeling of GMO products

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Bird flu makes raw milk dangerous to consume, mouse study finds

Pharma’s losing bet in New Jersey

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

FDA drug safety: Singulair case shows systemic surveillance flaws

knowledge

entertainment

hotspot

leisure time